Angion Biomedica Corp. Contracts & Agreements

Underwriting Agreement, dated June 28, 2024, between Elicio Therapeutics, Inc. and JonesTrading Institutional Services LLC, as representative of the several underwriters named... (Filed With SEC on July 1, 2024)

Form of Common Warrant (Filed With SEC on July 1, 2024)

Form of Pre-Funded Warrant (Filed With SEC on July 1, 2024)

Non-Employee Director Compensation Program (Filed With SEC on November 13, 2023)

Offer Letter between Elicio Therapeutics, Inc. and Brian Piekos, dated May 9, 2023 (Filed With SEC on June 2, 2023)

Form of Indemnification Agreement between the Company and each of its directions and officers (Filed With SEC on June 2, 2023)

Information Rights Letter, dated May 30, 2023, by and between Clal Biotechnology Industries Ltd. and Elicio Therapeutics, Inc (Filed With SEC on June 2, 2023)

Angion Biomedica Corp. Retention Bonus Plan (Filed With SEC on February 13, 2023)

Agreement and Plan of Merger and Reorganization, dated January 17, 2023, by and among Angion Biomedica Corp., Arkham Merger Sub, Inc. and Elicio Therapeutics, Inc (Filed With SEC on January 17, 2023)

Note Purchase Agreement, dated January 17, 2023, by and between Elicio Therapeutics, Inc. and Angion Biomedica Corp., and Form of Promissory Note (Filed With SEC on January 17, 2023)

Form of Angion Biomedica Corp. Stockholder Support Agreement, dated January 17, 2023 (Filed With SEC on January 17, 2023)

Form of Elicio Therapeutics, Inc. Stockholder Support Agreement, dated January 17, 2023 (Filed With SEC on January 17, 2023)

Form of Lock-Up Agreement, dated January 17, 2023 (Filed With SEC on January 17, 2023)

Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 30, 2022)

Amendment First Amendment dated July 1, 2021 to Licensing Agreement, dated November 6, 2020, by and between Angion Biomedica Corp. and Vifor (International) Ltd (Filed With SEC on March 30, 2022)

Separation Agreement, dated February 25, 2022, by and between Angion Biomedica Corp. and Itzhak D. Goldberg (Filed With SEC on March 30, 2022)

Separation Agreement, dated March 1, 2022, by and between Angion Biomedica Corp. and Elisha Goldberg (Filed With SEC on March 30, 2022)

First Amendment dated September 9, 2022 to Consulting Agreement, dated June 3, 2020, as amended, by and between Angion Biomedica Corp. and Gregory S. Curhan (Filed With SEC on March 30, 2022)

Second Amendment dated December 1, 2021 to Consulting Agreement, dated June 3, 2020, as amended, by and between Angion Biomedica Corp. and Gregory S. Curhan (Filed With SEC on March 30, 2022)

Third Amendment dated March 17, 2022 to Consulting Agreement, dated June 3, 2020, as amended, by and between Angion Biomedica Corp. and Gregory S. Curhan (Filed With SEC on March 30, 2022)

Non-Employee Director Compensation Program (Filed With SEC on March 30, 2022)

Amended and Restated Executive Separation Benefits Plan dated November 19, 2021 (Filed With SEC on March 30, 2022)

Supply Agreement, dated December 10, 2022, by and between Angion Biomedica Corp. and Solara Active Pharma Sciences, Ltd (Filed With SEC on March 30, 2022)

Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 30, 2021)

Stock Purchase Agreement, dated February 4, 2021, by and among Angion Biomedica Corp. and the purchasers named therein (Filed With SEC on February 9, 2021)

Form of Underwriting Agreement (Filed With SEC on February 1, 2021)

Form of Common Stock Certificate (Filed With SEC on February 1, 2021)

2021 Incentive Award Plan (Filed With SEC on February 1, 2021)

Form of Stock Option Grant Notice and Stock Option Agreement under the 2021 Incentive Award Plan (Filed With SEC on February 1, 2021)

Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2021 Incentive Award Plan (Filed With SEC on February 1, 2021)

Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2021 Incentive Award Plan (Filed With SEC on February 1, 2021)

2021 Employee Stock Purchase Plan (Filed With SEC on February 1, 2021)

ANGION BIOMEDICA CORP. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM (Filed With SEC on February 1, 2021)

Form of Warrant to Purchase Common Stock (Filed With SEC on January 15, 2021)

Form of Convertible Promissory Note (Filed With SEC on January 15, 2021)

Form of Broker Warrant to Purchase Common Stock (Filed With SEC on January 15, 2021)

Registration Rights Agreement, dated as of March 31, 2020, by and among Angion Biomedica Corp. and the investors party thereto (Filed With SEC on January 15, 2021)

Agreement of Lease, dated June 21, 2011, by and between Angion Biomedica Corp. and NovaPark LLC, as amended (Filed With SEC on January 15, 2021)

Licensing Agreement, dated August 22, 2018, by and between Angion Biomedica Corp. and Sinovant Sciences HK Limited (Filed With SEC on January 15, 2021)

Subcontractor Agreement, dated November 15, 2019, by and between Angion Biomedica Corp. and The Regents of the University of Michigan (Filed With SEC on January 15, 2021)

Licensing Agreement, dated November 6, 2020, by and between Angion Biomedica Corp. and Vifor (International) Ltd (Filed With SEC on January 15, 2021)

Second Amended and Restated 2015 Equity Incentive Plan (Filed With SEC on January 15, 2021)

Form of Incentive Stock Option Grant under 2015 Equity Incentive Plan (Filed With SEC on January 15, 2021)

Form of Non-Qualified Stock Option Grant under 2015 Equity Incentive Plan (Filed With SEC on January 15, 2021)

Form of Stock Option Exercise under 2015 Equity Incentive Plan (Filed With SEC on January 15, 2021)

Amended and Restated Employment Agreement, dated March 29, 2019, by and between Angion Biomedica Corp. and Jay R. Venkatesan (Filed With SEC on January 15, 2021)

Executive Employment Agreement, dated May 1, 2018, by and between Angion Biomedica Corp. and Itzhak D. Goldberg (Filed With SEC on January 15, 2021)

Executive Employment Agreement, dated December 17, 2018, by and between Angion Biomedica Corp. and John F. Neylan (Filed With SEC on January 15, 2021)

Offer Letter, dated November 27, 2019, as amended, by and between Angion Biomedica Corp. and Jennifer J. Rhodes (Filed With SEC on January 15, 2021)

Consulting Agreement, dated June 3, 2020, as amended, by and between Angion Biomedica Corp. and Greg Curhan (Filed With SEC on January 15, 2021)

Non-Employee Director Compensation Program (Filed With SEC on January 15, 2021)

Form of Indemnification Agreement for directors and officers (Filed With SEC on January 15, 2021)

Promissory Note and Agreement, dated April 21, 2020, by and between Angion Biomedica Corp. and Hanmi Bank (Filed With SEC on January 15, 2021)

LICENSE AGREEMENT (Filed With SEC on August 25, 2014)

UNDERWRITING AGREEMENT between ANGION BIOMEDICA CORP. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters (Filed With SEC on May 23, 2014)

Form of Representative’s Warrant Agreement (Filed With SEC on May 23, 2014)

ANGION BIOMEDICA CORP. 2014 NON-EMPLOYEEDIRECTOR COMPENSATION POLICY (Filed With SEC on May 23, 2014)

Form of Lock-Up Agreement (Filed With SEC on May 23, 2014)

EXECUTIVE EMPLOYMENTAGREEMENT (Filed With SEC on May 23, 2014)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 23, 2014)

IndemnificationAgreement (Filed With SEC on May 23, 2014)

ANGION BIOMEDICA CORP. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE (Filed With SEC on April 14, 2014)

ANGION BIOMEDICACORP. 2002 STOCKOPTION PLAN (Filed With SEC on April 14, 2014)

STOCK OPTION CERTIFICATE ThisStock Option is granted by ANGIONBIOMEDICA CORP. to (Filed With SEC on April 14, 2014)

ANGION BIOMEDICA CORP. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on April 14, 2014)

ANGION BIOMEDICA CORP. Stock Option Grant Notice Stock Option Grant under the Company’s 2014 Equity Incentive Plan (Filed With SEC on April 14, 2014)

CONSULTING AGREEMENT (Filed With SEC on April 14, 2014)

ANGION BIOMEDICA CORPORATION EMPLOYEE CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENT (Filed With SEC on April 14, 2014)

ANGIONBIOMEDICA CORPORATION EMPLOYMENT,CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENT (Filed With SEC on April 14, 2014)

ANGIONBIOMEDICA CORPORATION EMPLOYMENT,CONFIDENTIAL INFORMATION AND INVENTIONASSIGNMENT AGREEMENT (Filed With SEC on April 14, 2014)

angionbiomedica corporation employment,confidential information and INVENTION ASSIGNMENT AGREEMENT (Filed With SEC on April 14, 2014)

AGREEMENT OF LEASE BY AND BETWEEN NOVAPARK LLC Landlord, and ANGION BIOMEDICA CORP. Tenant. (Filed With SEC on April 14, 2014)

LEASE (Filed With SEC on April 14, 2014)

LICENSE AGREEMENT (Filed With SEC on April 14, 2014)

CONSULTINGAGREEMENT (Filed With SEC on April 14, 2014)

Notice of Award (Filed With SEC on April 14, 2014)

BACKGROUND (Filed With SEC on April 14, 2014)

Category

Industry

Companies

Contracts

Angion Biomedica Corp. Contracts & Agreements